SARAH JETT: Open Payments
NPI 1790420123 · NEWNAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$957 in 40 payments from 11 companies in 2025. Trend: 2023 $329 · 2024 $1,216 · 2025 $957
Food & beverage: $790Education: $166
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $358 |
| Regeneron Healthcare Solutions, Inc. | 4 | $165 |
| GENZYME CORPORATION | 2 | $96 |
| Arcutis Biotherapeutics, Inc. | 4 | $77 |
| Janssen Biotech, Inc. | 1 | $67 |
| Galderma Laboratories, L.P. | 3 | $56 |
| Lilly USA, LLC | 2 | $41 |
| UCB, Inc. | 1 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $29 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $24 |
Products named: DUPIXENT, SKYRIZI, RINVOQ, Zoryve, TREMFYA, BOTOX, TALTZ, NEMLUVIO.
Industry payments across GA — which companies pay providers there.
